Kevin Mathews - 25 Jul 2022 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role
SVP, Global Sales
Signature
/s/ Tom Sohn as attorney-in-fact for Kevin Mathews
Issuer symbol
AFIB
Transactions as of
25 Jul 2022
Transactions value $
$0
Form type
4
Filing time
01 Aug 2022, 18:04:40
Previous filing
01 Aug 2022
Next filing
09 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AFIB Common Stock 27.8K 25 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AFIB Employee Stock Options (Right to Buy) Disposed to Issuer -21.6K -37.83% 35.5K 25 Jul 2022 Common Stock 21.6K $18.00 Direct F1
transaction AFIB Employee Stock Options (Right to Buy) Award +21.6K +60.85% 57.1K 25 Jul 2022 Common Stock 21.6K $1.34 Direct F1
transaction AFIB Employee Stock Options (Right to Buy) Disposed to Issuer -15.5K -27.11% 41.6K 25 Jul 2022 Common Stock 15.5K $13.66 Direct F2
transaction AFIB Employee Stock Options (Right to Buy) Award +15.6K +37.79% 57.1K 25 Jul 2022 Common Stock 15.5K $1.34 Direct F2
transaction AFIB Employee Stock Options (Right to Buy) Disposed to Issuer -20K -35.06% 37.1K 25 Jul 2022 Common Stock 20K $2.41 Direct F3
transaction AFIB Employee Stock Options (Right to Buy) Award +20K +53.98% 57.1K 25 Jul 2022 Common Stock 20K $1.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on August 5, 2020, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F2 The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F3 The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.